Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

May 4, 2026

Scott Xiao, Co-Founder and CEO of Luminopia, is developing a novel, FDA -cleared VR-based treatment for neurovisual disorders with a primary focus on amblyopia, lazy eye, in children aged 4- 12 years old.  This approach uses popular TV shows to create an engaging, effective therapy that trains the eyes to work together and is designed as a replacement for traditional eye patching. Clinical data indicate that the vision improvements from this therapy are durable and that the VR approach is well-received by children and their parents.

Scott explains, "We are pioneering a new class of treatments using virtual reality to treat various neurovisual disorders. So these are conditions where patients have vision loss that's driven by deficiencies in the brain, in the visual cortex. We're starting with amblyopia, which is often known as lazy eye. It's the number one cause of vision loss in children around the world. And it's an area of significant unmet need. There hasn't been much in the way of new treatments for decades. Typically, patients will go through glasses followed by eye patches, which is exactly what it sounds like. You take a patch, and you stick it on your stronger eye for multiple hours a day. And that's a really challenging treatment for a lot of kids and families. So we saw an opportunity to use technology to create something better, something that would be more engaging and more effective."  

"We've developed a VR-based approach that takes popular TV shows like SpongeBob and Sesame Street and turns them into a treatment by modifying how the images are shown to each eye. And this technology has been extensively validated at this point in multiple clinical trials. It was cleared by the FDA, and it's now commercially available. So over the past year, we've really been making strides on the commercial front, increasing awareness for the product among physicians and patients, and securing insurance coverage for the product." 

#Luminopia #Amblyopia #PediatricOphthalmology #VirtualReality #DigitalTherapeutics #LazyEye #VisionTherapy #Optometry #PediatricCare #HealthcareInnovation #MedicalTechnology

luminopia.com

Listen to the podcast here

Luminopia